EC
EDIT icon

EcoR1 Capital’s Editas Medicine EDIT Stock Holding History

EcoR1 Capital’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-717,107
Closed -$12M – 43
2017
Q2 		$12M Buy
+717,107
New +$12.9M 2.14% 12
2017
Q1 		– Sell
-626,762
Closed -$10.2M – 36
2016
Q4 		$10.2M Buy
+626,762
New +$9.51M 3.24% 13
2016
Q3 		– Sell
-85,469
Closed -$2.08M – 34
2016
Q2 		$2.08M Sell
85,469
-2,452
-3% -$82.7K 0.82% 24
2016
Q1 		$3.04M Buy
+87,921
New +$2.31M 1.06% 26

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

EcoR1 Capital's EDIT Position: Q3 2017 in Review

EcoR1 Capital sold out of Editas Medicine (EDIT) in Q3 2017, closing a stake of 717,107 shares — an estimated $12M sold.

EcoR1 Capital first reported a position in EDIT in Q1 2016 and held it in 4 quarters. The position peaked at $12M in Q2 2017. 116 funds tracked by Wall St. Rank hold EDIT as of Q3 2017.

  • EcoR1 Capital reported no remaining Editas Medicine position as of Q3 2017 after selling out during the quarter.
  • EcoR1 Capital sold 717,107 Editas Medicine shares in Q3 2017, an estimated $12M.
  • EcoR1 Capital first reported a position in Editas Medicine in Q1 2016 and held it in 4 quarters.
  • EcoR1 Capital's Editas Medicine position peaked at $12M in Q2 2017.
  • 116 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2017.

Based on EcoR1 Capital's 13F filing for Q3 2017, filed 14 Nov 2017.